Literature DB >> 22040914

Non-SH2/PDZ reverse signaling by ephrins.

Ira O Daar1.   

Abstract

Great strides have been made regarding our understanding of the processes and signaling events influenced by Eph/ephrin signaling that play a role in cell adhesion and cell movement. However, the precise mechanisms by which these signaling events regulate cell and tissue architecture still need further resolution. The Eph/ephrin signaling pathways and the ability to regulate cell-cell adhesion and motility constitutes an impressive system for regulating tissue separation and morphogenesis (Pasquale, 2005, 2008 [1,2]). Moreover, the de-regulation of this signaling system is linked to the promotion of aggressive and metastatic tumors in humans [2]. In the following section, we discuss some of the interesting mechanisms by which ephrins can signal through their own intracellular domains (reverse signaling) either independent of forward signaling or in addition to forward signaling through a cognate receptor. In this review we discuss how ephrins (Eph ligands) "reverse signal" through their intracellular domains to affect cell adhesion and movement, but the focus is on modes of action that are independent of SH2 and PDZ interactions. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040914      PMCID: PMC3288889          DOI: 10.1016/j.semcdb.2011.10.012

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  94 in total

1.  Eph receptors and ephrins restrict cell intermingling and communication.

Authors:  G Mellitzer; Q Xu; D G Wilkinson
Journal:  Nature       Date:  1999-07-01       Impact factor: 49.962

2.  Regulation of repulsion versus adhesion by different splice forms of an Eph receptor.

Authors:  J Holmberg; D L Clarke; J Frisén
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

3.  Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.

Authors:  Peter W Janes; Nayanendu Saha; William A Barton; Momchil V Kolev; Sabine H Wimmer-Kleikamp; Eva Nievergall; Carl P Blobel; Juha-Pekka Himanen; Martin Lackmann; Dimitar B Nikolov
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

4.  EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.

Authors:  Ombretta Salvucci; Dragan Maric; Matina Economopoulou; Shuhei Sakakibara; Simone Merlin; Antonia Follenzi; Giovanna Tosato
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

5.  The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals.

Authors:  C A Cowan; M Henkemeyer
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

6.  Ephrin-B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation.

Authors:  Zhen Xu; Kwok-On Lai; Hai-Meng Zhou; Sheng-Cai Lin; Nancy Y Ip
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

7.  Loss of cell adhesion in Xenopus laevis embryos mediated by the cytoplasmic domain of XLerk, an erythropoietin-producing hepatocellular ligand.

Authors:  T L Jones; L D Chong; J Kim; R H Xu; H F Kung; I O Daar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

8.  Cdc42, Par6, and aPKC regulate Arp2/3-mediated endocytosis to control local adherens junction stability.

Authors:  Marios Georgiou; Eliana Marinari; Jemima Burden; Buzz Baum
Journal:  Curr Biol       Date:  2008-10-30       Impact factor: 10.834

9.  Cdc42 and Par proteins stabilize dynamic adherens junctions in the Drosophila neuroectoderm through regulation of apical endocytosis.

Authors:  Kathryn P Harris; Ulrich Tepass
Journal:  J Cell Biol       Date:  2008-12-08       Impact factor: 10.539

10.  When Wnts antagonize Wnts.

Authors:  Gilbert Weidinger; Randall T Moon
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

View more
  33 in total

Review 1.  The role of Eph/ephrin molecules in stromal–hematopoietic interactions.

Authors:  Thao M Nguyen; Agnieszka Arthur; Stan Gronthos
Journal:  Int J Hematol       Date:  2016-02       Impact factor: 2.490

Review 2.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 3.  Regulation of signaling interactions and receptor endocytosis in growing blood vessels.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 4.  Ephrin ligands and Eph receptors contribution to hematopoiesis.

Authors:  Giovanna Tosato
Journal:  Cell Mol Life Sci       Date:  2017-06-06       Impact factor: 9.261

Review 5.  A frog's view of EphrinB signaling.

Authors:  Yoo-Seok Hwang; Ira O Daar
Journal:  Genesis       Date:  2017-01       Impact factor: 2.487

Review 6.  Getting direction(s): The Eph/ephrin signaling system in cell positioning.

Authors:  Terren K Niethamer; Jeffrey O Bush
Journal:  Dev Biol       Date:  2018-01-31       Impact factor: 3.582

7.  Autonomous and non-autonomous roles for ephrin-B in interneuron migration.

Authors:  Asghar Talebian; Rachel Britton; Simon Ammanuel; Asim Bepari; Francis Sprouse; Shari G Birnbaum; Gábor Szabó; Nobuaki Tamamaki; Jay Gibson; Mark Henkemeyer
Journal:  Dev Biol       Date:  2017-09-22       Impact factor: 3.582

8.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

9.  The Smurf ubiquitin ligases regulate tissue separation via antagonistic interactions with ephrinB1.

Authors:  Yoo-Seok Hwang; Hyun-Shik Lee; Teddy Kamata; Kathleen Mood; Hee Jun Cho; Emily Winterbottom; Yon Ju Ji; Arvinder Singh; Ira O Daar
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

Review 10.  Targeting the Eph System with Peptides and Peptide Conjugates.

Authors:  Stefan J Riedl; Elena B Pasquale
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.